BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10580919)

  • 1. Putative inflammatory and immunological mechanisms in functional bowel disorders.
    Collins SM; Vallance B; Barbara G; Borgaonkar M
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):429-36. PubMed ID: 10580919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome.
    Rijnierse A; Nijkamp FP; Kraneveld AD
    Pharmacol Ther; 2007 Nov; 116(2):207-35. PubMed ID: 17719089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is irritable bowel syndrome a low-grade inflammatory bowel disease?
    Bercik P; Verdu EF; Collins SM
    Gastroenterol Clin North Am; 2005 Jun; 34(2):235-45, vi-vii. PubMed ID: 15862932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?].
    Mearin F; Perelló A; Balboa A
    Gastroenterol Hepatol; 2009 May; 32(5):364-72. PubMed ID: 19442413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional and inflammatory bowel disorders].
    Frieling T
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():139-42. PubMed ID: 16802539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
    Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
    Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postinfectious irritable bowel syndrome].
    Döbrönte Z; Lakner L; Sarang K
    Orv Hetil; 2006 Oct; 147(43):2077-80. PubMed ID: 17297754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?
    Quigley EM
    Chin J Dig Dis; 2005; 6(3):122-32. PubMed ID: 16045602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
    Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
    Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets.
    Kraneveld AD; Rijnierse A; Nijkamp FP; Garssen J
    Eur J Pharmacol; 2008 May; 585(2-3):361-74. PubMed ID: 18417115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological basis of inflammatory bowel disease: role of the microcirculation.
    Laroux FS; Grisham MB
    Microcirculation; 2001 Oct; 8(5):283-301. PubMed ID: 11687942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.
    Grover M; Herfarth H; Drossman DA
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):48-53. PubMed ID: 18848909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms.
    De Schepper HU; De Man JG; Moreels TG; Pelckmans PA; De Winter BY
    Aliment Pharmacol Ther; 2008 Apr; 27(8):621-37. PubMed ID: 18221407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will corticosteroids and other anti-inflammatory agents be effective for diarrhea-predominant irritable bowel syndrome?
    Crentsil V
    Med Hypotheses; 2005; 65(1):97-102. PubMed ID: 15893125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlap between irritable bowel syndrome and inflammatory bowel disease.
    Spiller RC
    Dig Dis; 2009; 27 Suppl 1():48-54. PubMed ID: 20203497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptides and inflammatory bowel disease.
    Margolis KG; Gershon MD
    Curr Opin Gastroenterol; 2009 Nov; 25(6):503-11. PubMed ID: 19816171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.
    Matricon J; Meleine M; Gelot A; Piche T; Dapoigny M; Muller E; Ardid D
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1009-31. PubMed ID: 23066886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.